covid 19 News and Research

RSS

Worries about emergency care costs keep older adults from seeking medical attention

Worries about what emergency care might cost them have kept some older adults from seeking medical attention even when they felt they might need it, a new study shows.

16 Dec 2022

Study finds pandemic-associated traumatic stress among mothers

The COVID-19 pandemic brought about sudden change and probably some amount of stress for most people in 2020.

16 Dec 2022

Exploring COVID-19 pandemic-related increases in hospitalizations among adolescents for mental health issues

Researchers conducted a retrospective, multisite cohort study among 11 to 17-year-old adolescents in the United States of America (USA) and France.

16 Dec 2022

Shielding measures conferred protection to pregnant individuals in early COVID-19 pandemic

Individuals who were already pregnant at the beginning of the COVID-19 pandemic had a 50 percent lower exposure to SARS-CoV-2 compared with those who became pregnant after the pandemic began and the general population, according to a new model created by Weill Cornell Medicine, NewYork-Presbyterian and University of Oxford investigators.

16 Dec 2022

Study provides deeper insights into skeletal muscle aging

A new research paper was published on the cover of Aging (listed as "Aging (Albany NY)" by Medline/PubMed and "Aging-US" by Web of Science) Volume 14, Issue 23, entitled, "Single nuclei profiling identifies cell specific markers of skeletal muscle aging, frailty, and senescence."

16 Dec 2022

Excess COVID-19-associated death estimates by World Health Organization

Researchers presented a comprehensive report on the estimated impact of the SARS-CoV-2 pandemic by estimating month-wise excess deaths for the years 2020 and 2021.

16 Dec 2022

Mucosal DNA vaccine provides protection against lethal SARS-CoV-2 in mice

Less known to the general public, mucosal vaccination via the mucus membranes could provide robust protection against SARS-CoV-2 infections.

16 Dec 2022

First-ever atlas of global airborne microbiome provides a wealth of insights into microbial communities

Bacteria are truly abundant across the Earth's surface, from the soil to the oceans. The microbial population of the air that surrounds us is comparatively unknown, but a research expedition led by PolyU scientists is about to change that.

16 Dec 2022

Current model for randomized clinical trials must be redesigned, world cardiology experts say

The current model for randomized clinical trials must be redesigned for the 21st century, according to the European Society of Cardiology (ESC), American Heart Association (AHA), World Heart Federation (WHF) and American College of Cardiology (ACC).

16 Dec 2022

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

Researchers investigated whether coronavirus disease 2019 (COVID-19)-associated chemosensory alterations were predictive of serological responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among United States (US) residents.

16 Dec 2022

Rehabilitation program for people with long COVID shows 'impressive' results

A rehabilitation program that helps people with long COVID reduce their symptoms and increase activity levels has shown "impressive" results, say scientists.

16 Dec 2022

Identity affirmation linked to better psychological health in Asian Americans facing online racism

Feeling proud of your background is key to one's mental health when dealing with online racism, a new study in the Journal of Applied Communication Research suggests.

16 Dec 2022

Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

Researchers investigated the cellular tropism, replication competence, persistence and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in humans, and associated histopathological changes in infected tissues.

16 Dec 2022

Structured analysis of personal criteria can make people more likely to save lives

When a person is facing a life-or-death decision, considering how certain aspects of the situation should affect their choice can make them more likely to save lives – according to new research published in Social Psychological and Personality Science.

16 Dec 2022

People of all age groups benefit more from COVID-19 vaccines than natural immunity, real-world study finds

In one of the first large, real-world studies comparing the effectiveness of COVID-19 vaccines versus natural immunity in protecting against death, hospitalizations and emergency department (ED) visits for any cause, including COVID, research-scientists from Regenstrief Institute, Indiana University School of Medicine and Vanderbilt University Medical Center report that people of all age groups benefited significantly more from vaccination than natural immunity acquired from a previous COVID infection.

16 Dec 2022

High performing primary care practices for patients with diabetes during the pandemic

Published in PLOS ONE, University of Minnesota Medical School researchers explored how high performing primary care practices organized care for patients with diabetes during the first months of the COVID-19 pandemic.

16 Dec 2022

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Researchers developed a one-dose subunit vaccine for the induction of durable, potent, and broad immunity against SARS-CoV-2.

16 Dec 2022

Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

Researchers used serological measurements from a longitudinal cohort to evaluate the use of binding antibodies against the SARS-CoV-2 spike protein receptor binding domain as correlates of protection against the immune evasive Omicron subvariants BA.1 and BA.2.

16 Dec 2022

Common psychiatric medications can give some protection against COVID-19

A new meta-analysis shows that psychiatric medications can give some protection against COVID-19, with the common antidepressant fluvoxamine showing the strongest effect.

16 Dec 2022

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Researchers investigated the efficacy of ritonavir and nirmatrelvir combination treatment in reducing the risk of COVID-19 severity outcomes such as hospital admissions and deaths when administered during the initial period of SARS-CoV-2 infections.

16 Dec 2022

covid 19 News and Research

Worries about emergency care costs keep older adults from seeking medical attention

Study finds pandemic-associated traumatic stress among mothers

Exploring COVID-19 pandemic-related increases in hospitalizations among adolescents for mental health issues

Shielding measures conferred protection to pregnant individuals in early COVID-19 pandemic

Study provides deeper insights into skeletal muscle aging

Excess COVID-19-associated death estimates by World Health Organization

Mucosal DNA vaccine provides protection against lethal SARS-CoV-2 in mice

First-ever atlas of global airborne microbiome provides a wealth of insights into microbial communities

Current model for randomized clinical trials must be redesigned, world cardiology experts say

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

Rehabilitation program for people with long COVID shows 'impressive' results

Identity affirmation linked to better psychological health in Asian Americans facing online racism

Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

Structured analysis of personal criteria can make people more likely to save lives

People of all age groups benefit more from COVID-19 vaccines than natural immunity, real-world study finds

High performing primary care practices for patients with diabetes during the pandemic

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

Common psychiatric medications can give some protection against COVID-19

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News